Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Author Correction: The prognostic effects of somatic mutations in ER-positive breast cancer.

Griffith OL, Spies NC, Anurag M, Griffith M, Luo J, Tu D, Yeo B, Kunisaki J, Miller CA, Krysiak K, Hundal J, Ainscough BJ, Skidmore ZL, Campbell K, Kumar R, Fronick C, Cook L, Snider JE, Davies S, Kavuri SM, Chang EC, Magrini V, Larson DE, Fulton RS, Liu S, Leung S, Voduc D, Bose R, Dowsett M, Wilson RK, Nielsen TO, Mardis ER, Ellis MJ.

Nat Commun. 2018 Nov 14;9(1):4850. doi: 10.1038/s41467-018-07407-3.

2.

Improved anal Cytology Sampling: Tush Brush Compared With Dacron Swab.

Ferris DG, Darragh TM, Kavuri S, Patel N, Waller JL, Goebel A.

J Low Genit Tract Dis. 2019 Jan;23(1):48-53. doi: 10.1097/LGT.0000000000000447.

PMID:
30407936
3.

The prognostic effects of somatic mutations in ER-positive breast cancer.

Griffith OL, Spies NC, Anurag M, Griffith M, Luo J, Tu D, Yeo B, Kunisaki J, Miller CA, Krysiak K, Hundal J, Ainscough BJ, Skidmore ZL, Campbell K, Kumar R, Fronick C, Cook L, Snider JE, Davies S, Kavuri SM, Chang EC, Magrini V, Larson DE, Fulton RS, Liu S, Leung S, Voduc D, Bose R, Dowsett M, Wilson RK, Nielsen TO, Mardis ER, Ellis MJ.

Nat Commun. 2018 Sep 4;9(1):3476. doi: 10.1038/s41467-018-05914-x. Erratum in: Nat Commun. 2018 Nov 14;9(1):4850.

4.

Collision metastasis of prostatic adenocarcinoma and urothelial carcinoma of the bladder.

Sellman DP, Peard L, Simpson G, Lancaster K, Kavuri S, Terris M, Madi R.

Urol Ann. 2018 Jul-Sep;10(3):342-344. doi: 10.4103/UA.UA_97_17.

5.

Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer.

Lei JT, Shao J, Zhang J, Iglesia M, Chan DW, Cao J, Anurag M, Singh P, He X, Kosaka Y, Matsunuma R, Crowder R, Hoog J, Phommaly C, Goncalves R, Ramalho S, Peres RMR, Punturi N, Schmidt C, Bartram A, Jou E, Devarakonda V, Holloway KR, Lai WV, Hampton O, Rogers A, Tobias E, Parikh PA, Davies SR, Li S, Ma CX, Suman VJ, Hunt KK, Watson MA, Hoadley KA, Thompson EA, Chen X, Kavuri SM, Creighton CJ, Maher CA, Perou CM, Haricharan S, Ellis MJ.

Cell Rep. 2018 Aug 7;24(6):1434-1444.e7. doi: 10.1016/j.celrep.2018.07.009.

6.

Repositioning Dopamine D2 Receptor Agonist Bromocriptine to Enhance Docetaxel Chemotherapy and Treat Bone Metastatic Prostate Cancer.

Yang Y, Mamouni K, Li X, Chen Y, Kavuri S, Du Y, Fu H, Kucuk O, Wu D.

Mol Cancer Ther. 2018 Sep;17(9):1859-1870. doi: 10.1158/1535-7163.MCT-17-1176. Epub 2018 Jun 15.

PMID:
29907594
7.

Tobacco-Specific Carcinogens Induce Hypermethylation, DNA Adducts, and DNA Damage in Bladder Cancer.

Jin F, Thaiparambil J, Donepudi SR, Vantaku V, Piyarathna DWB, Maity S, Krishnapuram R, Putluri V, Gu F, Purwaha P, Bhowmik SK, Ambati CR, von Rundstedt FC, Roghmann F, Berg S, Noldus J, Rajapakshe K, Gödde D, Roth S, Störkel S, Degener S, Michailidis G, Kaipparettu BA, Karanam B, Terris MK, Kavuri SM, Lerner SP, Kheradmand F, Coarfa C, Sreekumar A, Lotan Y, El-Zein R, Putluri N.

Cancer Prev Res (Phila). 2017 Oct;10(10):588-597. doi: 10.1158/1940-6207.CAPR-17-0198. Epub 2017 Aug 29.

8.

Label-free ferrohydrodynamic cell separation of circulating tumor cells.

Zhao W, Cheng R, Jenkins BD, Zhu T, Okonkwo NE, Jones CE, Davis MB, Kavuri SK, Hao Z, Schroeder C, Mao L.

Lab Chip. 2017 Sep 12;17(18):3097-3111. doi: 10.1039/c7lc00680b.

9.

Loss of MutL Disrupts CHK2-Dependent Cell-Cycle Control through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast Cancer.

Haricharan S, Punturi N, Singh P, Holloway KR, Anurag M, Schmelz J, Schmidt C, Lei JT, Suman V, Hunt K, Olson JA Jr, Hoog J, Li S, Huang S, Edwards DP, Kavuri SM, Bainbridge MN, Ma CX, Ellis MJ.

Cancer Discov. 2017 Oct;7(10):1168-1183. doi: 10.1158/2159-8290.CD-16-1179. Epub 2017 Aug 11.

10.

Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts.

Huang KL, Li S, Mertins P, Cao S, Gunawardena HP, Ruggles KV, Mani DR, Clauser KR, Tanioka M, Usary J, Kavuri SM, Xie L, Yoon C, Qiao JW, Wrobel J, Wyczalkowski MA, Erdmann-Gilmore P, Snider JE, Hoog J, Singh P, Niu B, Guo Z, Sun SQ, Sanati S, Kawaler E, Wang X, Scott A, Ye K, McLellan MD, Wendl MC, Malovannaya A, Held JM, Gillette MA, Fenyö D, Kinsinger CR, Mesri M, Rodriguez H, Davies SR, Perou CM, Ma C, Townsend RR, Chen X, Carr SA, Ellis MJ, Ding L.

Nat Commun. 2017 Apr 25;8:15479. doi: 10.1038/ncomms15479. No abstract available.

11.

Proteogenomic integration reveals therapeutic targets in breast cancer xenografts.

Huang KL, Li S, Mertins P, Cao S, Gunawardena HP, Ruggles KV, Mani DR, Clauser KR, Tanioka M, Usary J, Kavuri SM, Xie L, Yoon C, Qiao JW, Wrobel J, Wyczalkowski MA, Erdmann-Gilmore P, Snider JE, Hoog J, Singh P, Niu B, Guo Z, Sun SQ, Sanati S, Kawaler E, Wang X, Scott A, Ye K, McLellan MD, Wendl MC, Malovannaya A, Held JM, Gillette MA, Fenyö D, Kinsinger CR, Mesri M, Rodriguez H, Davies SR, Perou CM, Ma C, Reid Townsend R, Chen X, Carr SA, Ellis MJ, Ding L.

Nat Commun. 2017 Mar 28;8:14864. doi: 10.1038/ncomms14864.

12.

Ability of three desensitizing agents in dentinal tubule obliteration and durability: An in vitro study.

Pathan AB, Bolla N, Kavuri SR, Sunil CR, Damaraju B, Pattan SK.

J Conserv Dent. 2016 Jan-Feb;19(1):31-6. doi: 10.4103/0972-0707.173190.

13.

Multiple Discordant Histology After Nephrectomy: Descriptive Analysis and Outcomes.

Harlow BL, Klaassen Z, Holzman S, Reinstatler L, Franken AA, Kavuri SK, Terris MK, Master VA, Moses KA.

Clin Genitourin Cancer. 2016 Apr;14(2):e171-5. doi: 10.1016/j.clgc.2015.10.013. Epub 2015 Nov 2.

PMID:
26613833
14.

HER2 missense mutations have distinct effects on oncogenic signaling and migration.

Zabransky DJ, Yankaskas CL, Cochran RL, Wong HY, Croessmann S, Chu D, Kavuri SM, Red Brewer M, Rosen DM, Dalton WB, Cimino-Mathews A, Cravero K, Button B, Kyker-Snowman K, Cidado J, Erlanger B, Parsons HA, Manto KM, Bose R, Lauring J, Arteaga CL, Konstantopoulos K, Park BH.

Proc Natl Acad Sci U S A. 2015 Nov 10;112(45):E6205-14. doi: 10.1073/pnas.1516853112. Epub 2015 Oct 27.

15.

HER2-Mutated Breast Cancer Responds to Treatment With Single-Agent Neratinib, a Second-Generation HER2/EGFR Tyrosine Kinase Inhibitor.

Ben-Baruch NE, Bose R, Kavuri SM, Ma CX, Ellis MJ.

J Natl Compr Canc Netw. 2015 Sep;13(9):1061-4.

16.

HER2 activating mutations are targets for colorectal cancer treatment.

Kavuri SM, Jain N, Galimi F, Cottino F, Leto SM, Migliardi G, Searleman AC, Shen W, Monsey J, Trusolino L, Jacobs SA, Bertotti A, Bose R.

Cancer Discov. 2015 Aug;5(8):832-41. doi: 10.1158/2159-8290.CD-14-1211.

17.

A Heterogeneous Renal Mass and Arm Pain in a 38-Year-old African American Female.

Klaassen Z, Peard L, Wilhelm S, Coulson HC, Li Q, Kavuri SK, Terris MK, Moses KA.

Urology. 2015 Jun;85(6):1229-32. doi: 10.1016/j.urology.2015.02.002. Epub 2015 Mar 31. No abstract available.

PMID:
25840460
18.

Clear cell adenocarcinoma of the prostate: a rare oncologic entity in a 42-year-old African American man.

Klaassen Z, Cleveland C, McCraw CO, Burnette JO, Franken A, Wilhelm S, Kavuri SK, Biddinger PW, Terris MK, Moses KA.

Urology. 2014 Nov;84(5):997-1000. doi: 10.1016/j.urology.2014.06.042. Epub 2014 Sep 10. No abstract available.

PMID:
25217452
19.

A 55-Year-Old Man with Stage IV Squamous Cell Carcinoma of the Right Groin after External Beam Radiation for Testicular Cancer.

Ibilibor C, Wells J, Kavuri S, Moses KA.

Case Rep Urol. 2014;2014:346247. doi: 10.1155/2014/346247. Epub 2014 Jun 15.

20.

6p22.3 amplification as a biomarker and potential therapeutic target of advanced stage bladder cancer.

Shen H, Morrison CD, Zhang J, Underwood W 3rd, Yang N, Frangou C, Eng K, Head K, Bollag RJ, Kavuri SK, Rojiani AM, Li Y, Yan L, Hill A, Woloszynska-Read A, Wang J, Liu S, Trump DL, Candace JS.

Oncotarget. 2013 Nov;4(11):2124-34.

21.
22.

P21 activated kinase-1 (Pak1) promotes prostate tumor growth and microinvasion via inhibition of transforming growth factor β expression and enhanced matrix metalloproteinase 9 secretion.

Goc A, Al-Azayzih A, Abdalla M, Al-Husein B, Kavuri S, Lee J, Moses K, Somanath PR.

J Biol Chem. 2013 Feb 1;288(5):3025-35. doi: 10.1074/jbc.M112.424770. Epub 2012 Dec 20.

23.

Activating HER2 mutations in HER2 gene amplification negative breast cancer.

Bose R, Kavuri SM, Searleman AC, Shen W, Shen D, Koboldt DC, Monsey J, Goel N, Aronson AB, Li S, Ma CX, Ding L, Mardis ER, Ellis MJ.

Cancer Discov. 2013 Feb;3(2):224-37. doi: 10.1158/2159-8290.CD-12-0349. Epub 2012 Dec 7.

24.

Adaptive estimation of EEG-rhythms for optimal band identification in BCI.

Veluvolu KC, Wang Y, Kavuri SS.

J Neurosci Methods. 2012 Jan 15;203(1):163-72. doi: 10.1016/j.jneumeth.2011.08.035. Epub 2011 Sep 6.

PMID:
21911006
25.

Maxillary canine with two root canals.

Bolla N, Kavuri SR.

J Conserv Dent. 2011 Jan;14(1):80-2. doi: 10.4103/0972-0707.80726.

26.

Cellular FLICE-inhibitory protein (cFLIP) isoforms block CD95- and TRAIL death receptor-induced gene induction irrespective of processing of caspase-8 or cFLIP in the death-inducing signaling complex.

Kavuri SM, Geserick P, Berg D, Dimitrova DP, Feoktistova M, Siegmund D, Gollnick H, Neumann M, Wajant H, Leverkus M.

J Biol Chem. 2011 May 13;286(19):16631-46. doi: 10.1074/jbc.M110.148585. Epub 2011 Mar 22.

27.

Glycogen synthase kinase-3β is a crucial mediator of signal-induced RelB degradation.

Neumann M, Klar S, Wilisch-Neumann A, Hollenbach E, Kavuri S, Leverkus M, Kandolf R, Brunner-Weinzierl MC, Klingel K.

Oncogene. 2011 May 26;30(21):2485-92. doi: 10.1038/onc.2010.580. Epub 2011 Jan 10.

PMID:
21217772
28.

Granulosa cell tumor of the ovary: cytologic findings.

Kavuri S, Kulkarni R, Reid-Nicholson M.

Acta Cytol. 2010 Jul-Aug;54(4):551-9.

PMID:
20715655
29.

The contact allergen nickel sensitizes primary human endothelial cells and keratinocytes to TRAIL-mediated apoptosis.

Schmidt M, Hupe M, Endres N, Raghavan B, Kavuri S, Geserick P, Goebeler M, Leverkus M.

J Cell Mol Med. 2010 Jun;14(6B):1760-76. doi: 10.1111/j.1582-4934.2009.00823.x. Epub 2009 Jun 16.

30.

Plasmablastic lymphoma: Cytologic findings in 5 cases with unusual presentation.

Reid-Nicholson M, Kavuri S, Ustun C, Crawford J, Nayak-Kapoor A, Ramalingam P.

Cancer. 2008 Oct 25;114(5):333-41. doi: 10.1002/cncr.23794.

31.

EBV positivity in primary cutaneous large B-cell lymphoma with immunophenotypic features of leg type: an isolated incident or something more significant?

Gaitonde S, Kavuri S, Alagiozian-Angelova V, Peace D, Worobec S.

Acta Oncol. 2008;47(3):461-4. Epub 2007 Sep 25. No abstract available.

PMID:
17896194
32.

Sustained JNK activation in response to tumor necrosis factor is mediated by caspases in a cell type-specific manner.

Wicovsky A, Müller N, Daryab N, Marienfeld R, Kneitz C, Kavuri S, Leverkus M, Baumann B, Wajant H.

J Biol Chem. 2007 Jan 26;282(4):2174-83. Epub 2006 Nov 22.

33.

Oxidative stress in pediatric nephrotic syndrome.

Kamireddy R, Kavuri S, Devi S, Vemula H, Chandana D, Harinarayanan S, James R, Rao A.

Clin Chim Acta. 2002 Nov;325(1-2):147-50.

PMID:
12367779
34.

Low-dose intrathecal-meperidine for lower limb orthopaedic surgery.

Kavuri S, Robalino J, Janardhan Y, Shevde K.

Can J Anaesth. 1990 Nov;37(8):947-8. No abstract available. Erratum in: Can J Anaesth 1991 Mar;38(2):263.

PMID:
2253305

Supplemental Content

Loading ...
Support Center